EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A Novel Therapy for Keloid Following Toe Syndactyly Division in Children: 1470 nm Laser and Glucocorticoid Injection (1470 LAGI)

Xinxian Meng, Chunxiao Cui, Ke Wen, Xueqian Wang, Chengyao Han, Yuhao Sun, Jingshu Wu, Peiru Min, Fabio Nicoli, Hua Li, Yixin Zhang, Ke Li

Dermatologic Therapy · 2026-01 · 2026 (1)

DOI: 10.1155/dth/6625620 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Dermatologic Therapy, online erschienen am 13.04.2026. Verfasst von Xinxian Meng und 11 weiteren Autor:innen. Die Arbeit nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Shanghai Municipal Education Commission.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Keloid development following toe syndactyly division is a rare but troublesome condition, which can impose both esthetic and functional burden. Currently, there is no effective treatment for this condition. The present study proposed a new treatment for keloid after syndactyly division by 1470 nm laser and glucocorticoid injection (1470 LAGI). This study aimed to evaluate the efficacy of this treatment modality.

Methods

A retrospective study was conducted on 12 patients with 36 keloid cases, who underwent treatment with 1470 LAGI. VSS scores were applied for keloid evaluation (pigmentation, vascularity, pliability, and height). VAS was applied for assessing pain and itching, and the recovery rate was recorded.

Results

This study showed that the 1470 LAGI can improve the pathological status of keloids from toe syndactyly division ( p < 0.001), with a recovery rate of 30.56%. Itching and pain also significantly improved ( p < 0.001).

Conclusion

In terms of vascularity, pigmentation, pliability, and height, 1470 LAGI led to keloid regression after toe syndactyly division, with a recovery rate of 30.56%. Besides, the combined treatment significantly decreased the episodes of itching and pain, thereby improving the quality of life. Therefore, it is an effective minimally invasive treatment for keloid following toe syndactyly division in children.

Förderung

  • National Natural Science Foundation of China
  • Shanghai Municipal Education Commission

Zitieren

APA

Meng, X., Cui, C., Wen, K., Wang, X., Han, C., Sun, Y., Wu, J., Min, P., Nicoli, F., Li, H., Zhang, Y., & Li, K. (2026). A Novel Therapy for Keloid Following Toe Syndactyly Division in Children: 1470 nm Laser and Glucocorticoid Injection (1470 LAGI). Dermatologic Therapy, 2026(1). https://doi.org/10.1155/dth/6625620

Vancouver

Meng X, Cui C, Wen K, Wang X, Han C, Sun Y, et al. A Novel Therapy for Keloid Following Toe Syndactyly Division in Children: 1470 nm Laser and Glucocorticoid Injection (1470 LAGI). Dermatologic Therapy. 2026;2026(1). doi:10.1155/dth/6625620

BibTeX
@article{Meng2026,
  author = {Meng, Xinxian and Cui, Chunxiao and Wen, Ke and Wang, Xueqian and Han, Chengyao and Sun, Yuhao and Wu, Jingshu and Min, Peiru and Nicoli, Fabio and Li, Hua and Zhang, Yixin and Li, Ke},
  title = {A Novel Therapy for Keloid Following Toe Syndactyly Division in Children: 1470 nm Laser and Glucocorticoid Injection (1470 LAGI)},
  journal = {Dermatologic Therapy},
  year = {2026},
  volume = {2026},
  number = {1},
  doi = {10.1155/dth/6625620}
}
Kostenlos starten →